We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

AstraZeneca plc, BP plc and Unilever plc are Brexit dividend WINNERS

AstraZeneca plc (LON: AZN), BP plc (LON: BP) and Unilever plc (LON: ULVR) are proving a handy foxhole amid a barrage of Brexit bad news, says Harvey Jones.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

Not every company stock collapsed in the aftermath of the shock Brexit referendum result, canny investors spotted opportunities as well as threats to their portfolio. As the pound collapsed, income seekers realised that companies with strong overseas earnings should prove more rewarding. Here are three stocks that are likely to be Brexit dividend winners.

Astra shines

Pharmaceuticals giant AstraZeneca (LSE: AZN) ended Friday 3.41% higher and is up 10.36% across the last turbulent week. Over the same period, sterling has fallen from around $1.46 to $1.33, a drop of around 9%. That is far from a coincidence. AstraZeneca generate more than 90% of its profits overseas but has a large cost base in the UK, which will be less of a burden as its overseas earnings rise relative to the pound.

Should you buy AstraZeneca Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

AstraZeneca converts its dividends into pence on the day results are announced – twice a year in March and September – and although we don’t know whether the dollar will remain strong against sterling over the longer term, that’s certainly the way to bet right now. The company suffered during recent sterling strength, with Q1 results showing revenue up 5% to $6,115m, but just 1% at actual exchange rates. That now looks set to reverse. Trading at 13.3 times earnings it isn’t overpriced, while the yield is healthy at 4.9%. The big question is whether chief executive Pascal Soriot can replenish AstraZeneca’s drugs pipeline, but for now the dollar pipeline will be flowing.

Brexit petroleum

Friday’s result may have divided the nation but it united investors in pursuit of oil major BP (LSE: BP), whose share price rose 1.73% on the day and now stands nearly 6% higher than it did a week ago. In January, chief executive Bob Dudley warned that investment in the UK energy sector could fall if Britain voted to leave the EU. But the company put on a brave face after the result, publicly stating that “we do not currently expect it to have a significant impact on BP’s business or investments in the UK and continental Europe, nor on the location of our headquarters or our staff“. Investors are taking that at face value today.

The uncertainty has set back the oil price recovery, with Brent crude falling from over $50 to around $47 a barrel, but markets are calculating that this is only temporary. Sterling weakness is likely to last much longer and with oil priced in dollars BP’s revenues will be the beneficiary. As will income seekers, given that BP declares its dividend in dollars, and its current yield of 7.1% has just got even juicier.

Uni winner

Household goods giant Unilever (LSE: ULVR) is another instant Brexit winner rising 3.11% on the day and trading 6.72% higher over the week. Almost 60% of its revenues come from emerging markets, with dollar and euro earnings on top, which is good news when sterling is plunging against a basket of global currencies. 

Unilever reports in euros and UK investors have already benefitted from pre-referendum uncertainty: Unilever recently raised its Q1 dividend by 6% to EUR0.3201 per share, which equated to 17% in sterling terms. We can expect more of that, unless the euro comes under greater pressure as Brexit contagion spreads.

Harvey Jones has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Unilever. The Motley Fool UK has recommended AstraZeneca and BP. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Elevated view over city of London skyline
Investing Articles

With a 5.8% yield, how much is needed in a Stocks and Shares ISA for £1,000 of monthly passive income?

Muhammad Cheema looks at British Land and its 5.8% dividend yield. How many of its shares are needed in a…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

Why are these FTSE 100 growth and dividend stocks so cheap?

Searching for the greatest FTSE 100 bargain stocks to buy? Royston Wild picks out two to consider with low PEG…

Read more »

many happy international football fans watching tv
Investing Articles

3 cheap FTSE 250 stocks to consider buying before the 2026 World Cup kicks off

With the World Cup less than a week away, our writer highlights a trio of UK stocks to consider buying.…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

I’m aggressively buying this S&P 500 growth stock for my ISA while it’s down 40%

This S&P 500 tech stock is well off its highs at the moment. But it may not be at depressed…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

What on earth’s happening to the Barclays share price?

The Barclays share price has been jumping around of late and is up 11% in the past month. Ken Hall…

Read more »

A colourful firework display
Investing Articles

See what £12,000 in explosive JD Sports shares 1 month ago is worth today

After years of doom and gloom, JD sport shares are finally putting on a show. Harvey Jones examines how long…

Read more »

Businessman hand stacking money coins with virtual percentage icons
Investing Articles

The BP share price is on a knife edge – so where does it go next?

Harvey Jones exams why the BP share price has been surprisingly jumpy, even as the oil price spikes. Should investors…

Read more »

Wall Street sign in New York City
Investing Articles

Is the FTSE 100 at risk from an overheated US stock market?

Christopher Ruane explains why the UK market could suffer if its bigger US cousin sinks -- and why he's still…

Read more »